Last 12 months
Inside the activity.
0 purchase rows · 457 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 47 |
| Dec 2025 | 0 | 21 |
| Jan 2026 | 0 | 41 |
| Feb 2026 | 0 | 21 |
| Mar 2026 | 0 | 54 |
| Apr 2026 | 0 | 29 |
| May 2026 | 0 | 33 |
| Jun 2026 | 0 | 68 |
| Jul 2026 | 0 | 47 |
| Aug 2026 | 0 | 33 |
| Sep 2026 | 0 | 59 |
| Oct 2026 | 0 | 4 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 23, 2024 Filed May 25, 2024 01:05 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 264 | $107.77 | $28,449.96 |
DisclosureSEC source: 0001415889-24-014600 · form4-05242024_090501.xml · nonDerivative · entry 3 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Indirect · By Caraluna 2 Trust Disclosed balance after: 68,818 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.39 to $108.26 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities. Read SEC document |
| May 23, 2024 Filed May 25, 2024 01:05 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 156 | $109.16 | $17,028.74 |
DisclosureSEC source: 0001415889-24-014600 · form4-05242024_090501.xml · nonDerivative · entry 2 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Indirect · By Caraluna 1 Trust Disclosed balance after: 68,582 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.79 to $109.20 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities. Read SEC document |
| May 23, 2024 Filed May 25, 2024 01:05 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 344 | $107.90 | $37,118.12 |
DisclosureSEC source: 0001415889-24-014600 · form4-05242024_090501.xml · nonDerivative · entry 1 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Indirect · By Caraluna 1 Trust Disclosed balance after: 68,738 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.40 to $108.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities. Read SEC document |
| May 16, 2024 Filed May 18, 2024 01:35 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
GiftCommon Stock | 11,853 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-013651 · form4-05172024_090505.xml · nonDerivative · entry 1 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 307,208 F1 · shares: Reflects the transfer of shares as a bona fide gift to a charitable foundation. Read SEC document |
| May 15, 2024 Filed May 18, 2024 01:35 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
SaleCommon Stock | 3,320 | $107.59 | $357,201.12 |
DisclosureSEC source: 0001415889-24-013650 · form4-05172024_090501.xml · nonDerivative · entry 2 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 219,456 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.2920 to $108.02 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 15, 2024 Filed May 18, 2024 01:35 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
SaleCommon Stock | 3,459 | $106.59 | $368,710.03 |
DisclosureSEC source: 0001415889-24-013650 · form4-05172024_090501.xml · nonDerivative · entry 1 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 222,776 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.10 to $107.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2024 Filed May 11, 2024 01:35 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $19.68 | $0.00 |
DisclosureSEC source: 0001415889-24-012937 · form4-05102024_090508.xml · derivative · entry 6 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 30,000 shares Expires 2029-03-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option shares are fully exercisable. Read SEC document |
| May 10, 2024 Filed May 11, 2024 01:35 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
SaleCommon Stock | 10,350 | $108.10 | $1,118,783.25 |
DisclosureSEC source: 0001415889-24-012937 · form4-05102024_090508.xml · nonDerivative · entry 5 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 204,495 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.55 to $108.11 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2024 Filed May 11, 2024 01:35 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
SaleCommon Stock | 4,255 | $104.03 | $442,633.61 |
DisclosureSEC source: 0001415889-24-012937 · form4-05102024_090508.xml · nonDerivative · entry 4 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 214,845 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.85 to $104.77 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2024 Filed May 11, 2024 01:35 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
SaleCommon Stock | 9,398 | $102.91 | $967,151.94 |
DisclosureSEC source: 0001415889-24-012937 · form4-05102024_090508.xml · nonDerivative · entry 3 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 219,100 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.83 to $103.55 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2024 Filed May 11, 2024 01:35 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
SaleCommon Stock | 5,997 | $101.55 | $608,998.35 |
DisclosureSEC source: 0001415889-24-012937 · form4-05102024_090508.xml · nonDerivative · entry 2 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 228,498 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.30 to $102.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2024 Filed May 11, 2024 01:35 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
Exercise / conversionCommon Stock | 30,000 | $19.68 | $590,400.00 |
DisclosureSEC source: 0001415889-24-012937 · form4-05102024_090508.xml · nonDerivative · entry 1 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 234,495 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2024 Filed May 11, 2024 01:35 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 90 | $107.48 | $9,673.20 |
DisclosureSEC source: 0001415889-24-012936 · form4-05102024_090506.xml · nonDerivative · entry 5 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 319,061 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023. Read SEC document |
| May 10, 2024 Filed May 11, 2024 01:35 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 611 | $106.32 | $64,959.26 |
DisclosureSEC source: 0001415889-24-012936 · form4-05102024_090506.xml · nonDerivative · entry 4 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 319,151 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023. F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.16 to $106.98 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2024 Filed May 11, 2024 01:35 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 660 | $105.51 | $69,636.01 |
DisclosureSEC source: 0001415889-24-012936 · form4-05102024_090506.xml · nonDerivative · entry 3 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 319,762 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.86 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2024 Filed May 11, 2024 01:35 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 990 | $104.60 | $103,558.85 |
DisclosureSEC source: 0001415889-24-012936 · form4-05102024_090506.xml · nonDerivative · entry 2 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 320,422 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.99 to $104.95 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2024 Filed May 11, 2024 01:35 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 349 | $103.06 | $35,966.93 |
DisclosureSEC source: 0001415889-24-012936 · form4-05102024_090506.xml · nonDerivative · entry 1 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 321,412 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.87 to $103.57 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 397 shares acquired under the Issuer's 2015 Employee Stock Purchase Plan on April 29, 2024. Read SEC document |
| May 08, 2024 Filed May 11, 2024 01:35 UTC |
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
|
Exercise / conversionStock Option (right to buy) · Derivative | 215,000 | $0.00 Strike: $5.40 | $0.00 |
DisclosureSEC source: 0001415889-24-012935 · form4-05102024_090501.xml · derivative · entry 3 Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 398,496 Underlying: Common Stock · 215,000 shares Expires 2024-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option shares are fully exercisable. Read SEC document |
| May 08, 2024 Filed May 11, 2024 01:35 UTC |
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
|
Exercise / conversionCommon Stock | 215,000 | $5.40 | $1,159,989.50 |
DisclosureSEC source: 0001415889-24-012935 · form4-05102024_090501.xml · nonDerivative · entry 1 Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,290,648 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2024 Filed May 4, 2024 01:35 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 200 | $95.64 | $19,128.00 |
DisclosureSEC source: 0001415889-24-012265 · form4-05032024_090501.xml · nonDerivative · entry 4 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,542 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.50 to $95.78 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 01, 2024 Filed May 4, 2024 01:35 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 400 | $94.70 | $37,879.00 |
DisclosureSEC source: 0001415889-24-012265 · form4-05032024_090501.xml · nonDerivative · entry 3 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,742 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.39 to $94.96 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 01, 2024 Filed May 4, 2024 01:35 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 866 | $93.88 | $81,298.52 |
DisclosureSEC source: 0001415889-24-012265 · form4-05032024_090501.xml · nonDerivative · entry 2 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,142 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.34 to $94.31 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 01, 2024 Filed May 4, 2024 01:35 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 400 | $92.60 | $37,038.00 |
DisclosureSEC source: 0001415889-24-012265 · form4-05032024_090501.xml · nonDerivative · entry 1 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,008 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.20 to $93.05 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 29, 2024 Filed May 2, 2024 01:05 UTC |
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
|
SaleCommon Stock | 929 | $93.14 | $86,525.85 |
DisclosureSEC source: 0001415889-24-011942 · form4-05012024_090510.xml · nonDerivative · entry 1 Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 110,748 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023. Read SEC document |
| April 29, 2024 Filed May 2, 2024 01:05 UTC |
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
|
SaleCommon Stock | 1,196 | $93.14 | $111,393.89 |
DisclosureSEC source: 0001415889-24-011943 · form4-05012024_090513.xml · nonDerivative · entry 1 Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,833 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023. Read SEC document |
| April 29, 2024 Filed May 2, 2024 01:05 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
SaleCommon Stock | 4,084 | $93.14 | $380,378.45 |
DisclosureSEC source: 0001415889-24-011939 · form4-05012024_090503.xml · nonDerivative · entry 1 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 226,235 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023. Read SEC document |
| April 29, 2024 Filed May 2, 2024 01:05 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 1,238 | $93.14 | $115,305.71 |
DisclosureSEC source: 0001415889-24-011938 · form4-05012024_090501.xml · nonDerivative · entry 1 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,408 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023. Read SEC document |
| April 29, 2024 Filed May 2, 2024 01:05 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
SaleCommon Stock | 1,057 | $93.14 | $98,447.61 |
DisclosureSEC source: 0001415889-24-011940 · form4-05012024_090505.xml · nonDerivative · entry 1 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 204,495 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023. Read SEC document |
| April 26, 2024 Filed Apr 27, 2024 01:35 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 751 | $92.00 | $69,092.00 |
DisclosureSEC source: 0001415889-24-011631 · form4-04262024_090401.xml · nonDerivative · entry 3 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,646 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. Read SEC document |
| April 26, 2024 Filed Apr 30, 2024 20:35 UTC |
HEALY JAMESDirector
|
GrantCommon Stock | 210 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-011830 · form4-04302024_080415.xml · nonDerivative · entry 1 HEALY JAMES · CIK 0001245624 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,710 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $19,375 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| April 26, 2024 Filed May 1, 2024 00:35 UTC |
ROSENMAN HERMDirector
|
GrantCommon Stock | 244 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-011826 · form4-04302024_080407.xml · nonDerivative · entry 2 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,417 F3 · shares: Represents the issuance of RSUs to the Reporting Person in lieu of quarterly retainer fees of $22,500 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| April 26, 2024 Filed May 1, 2024 00:35 UTC |
ROSENMAN HERMDirector
|
GrantCommon Stock | 488 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-011826 · form4-04302024_080407.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,173 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over one year. 25% of the RSUs vest immediately and the remaining RSUs vest in three equal quarterly installments thereafter. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| April 26, 2024 Filed May 1, 2024 00:35 UTC |
BOTHA ROELOFDirector
|
GrantCommon Stock | 278 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-011825 · form4-04302024_080401.xml · nonDerivative · entry 2 BOTHA ROELOF · CIK 0001222287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,042 F3 · shares: Represents the issuance of RSUs to the Reporting Person in lieu of quarterly retainer fees of $25,625 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| April 26, 2024 Filed May 1, 2024 00:35 UTC |
BOTHA ROELOFDirector
|
GrantCommon Stock | 488 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-011825 · form4-04302024_080401.xml · nonDerivative · entry 1 BOTHA ROELOF · CIK 0001222287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,764 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over one year. 25% of the RSUs vest immediately and the remaining RSUs vest in three equal quarterly installments thereafter. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| April 26, 2024 Filed May 1, 2024 00:35 UTC |
Baynes Roy D.Director
|
GrantCommon Stock | 169 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-011829 · form4-04302024_080413.xml · nonDerivative · entry 1 Baynes Roy D. · CIK 0001680739 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,576 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $15,625 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| April 26, 2024 Filed May 1, 2024 00:35 UTC |
Marcus Gail BoxerDirector
|
GrantCommon Stock | 488 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-011828 · form4-04302024_080411.xml · nonDerivative · entry 1 Marcus Gail Boxer · CIK 0001702176 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,634 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over one year. 25% of the RSUs vest immediately and the remaining RSUs vest in three equal quarterly installments thereafter. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| April 26, 2024 Filed May 1, 2024 00:35 UTC |
Chapman Rowan EDirector
|
GrantCommon Stock | 488 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-011827 · form4-04302024_080409.xml · nonDerivative · entry 1 Chapman Rowan E · CIK 0001786240 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,861 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over one year. 25% of the RSUs vest immediately and the remaining RSUs vest in three equal quarterly installments thereafter. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| April 25, 2024 Filed Apr 27, 2024 01:35 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 705 | $89.55 | $63,132.75 |
DisclosureSEC source: 0001415889-24-011631 · form4-04262024_090401.xml · nonDerivative · entry 2 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,397 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. Read SEC document |
| April 25, 2024 Filed Apr 27, 2024 01:35 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 500 | $89.55 | $44,775.00 |
DisclosureSEC source: 0001415889-24-011632 · form4-04262024_090404.xml · nonDerivative · entry 2 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Indirect · By Caraluna 2 Trust Disclosed balance after: 69,082 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023. F2 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities. Read SEC document |
| April 25, 2024 Filed Apr 27, 2024 01:35 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 500 | $89.55 | $44,775.00 |
DisclosureSEC source: 0001415889-24-011632 · form4-04262024_090404.xml · nonDerivative · entry 1 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Indirect · By Caraluna 1 Trust Disclosed balance after: 69,082 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023. F2 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities. Read SEC document |
| April 24, 2024 Filed Apr 27, 2024 01:35 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 937 | $93.00 | $87,140.16 |
DisclosureSEC source: 0001415889-24-011631 · form4-04262024_090401.xml · nonDerivative · entry 1 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 72,102 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. Read SEC document |
| April 23, 2024 Filed Apr 24, 2024 01:35 UTC |
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
|
SaleCommon Stock | 522 | $91.38 | $47,699.94 |
DisclosureSEC source: 0001415889-24-011404 · form4-04232024_090411.xml · nonDerivative · entry 1 Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,677 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021 and January 28, 2022, respectively. Read SEC document |
| April 23, 2024 Filed Apr 24, 2024 01:35 UTC |
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
|
SaleCommon Stock | 531 | $91.38 | $48,522.36 |
DisclosureSEC source: 0001415889-24-011405 · form4-04232024_090418.xml · nonDerivative · entry 1 Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 117,029 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 22, 2021 and January 28, 2022, respectively. Read SEC document |
| April 23, 2024 Filed Apr 24, 2024 01:35 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
SaleCommon Stock | 2,552 | $91.38 | $233,199.72 |
DisclosureSEC source: 0001415889-24-011403 · form4-04232024_090405.xml · nonDerivative · entry 3 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 230,319 F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021 and January 28, 2022. Read SEC document |
| April 23, 2024 Filed Apr 24, 2024 01:35 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 1,523 | $91.38 | $139,170.52 |
DisclosureSEC source: 0001415889-24-011402 · form4-04232024_090401.xml · nonDerivative · entry 4 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,039 F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, October 22, 2021, and January 28, 2022. Read SEC document |
| April 23, 2024 Filed Apr 24, 2024 01:35 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
SaleCommon Stock | 787 | $91.38 | $71,915.43 |
DisclosureSEC source: 0001415889-24-011406 · form4-04232024_090420.xml · nonDerivative · entry 3 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 205,552 F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021 and January 28, 2022. Read SEC document |
| April 22, 2024 Filed Apr 24, 2024 01:35 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-011402 · form4-04232024_090401.xml · derivative · entry 7 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vested on October 22, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter. F5 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vested on October 22, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter. Read SEC document |
| April 22, 2024 Filed Apr 24, 2024 01:35 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-011402 · form4-04232024_090401.xml · nonDerivative · entry 3 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,562 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| April 21, 2024 Filed Apr 24, 2024 01:35 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-011403 · form4-04232024_090405.xml · derivative · entry 5 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,324 Underlying: Common Stock · 1,775 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter. F4 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter. Read SEC document |
| April 21, 2024 Filed Apr 24, 2024 01:35 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
Exercise / conversionCommon Stock | 1,775 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-011403 · form4-04232024_090405.xml · nonDerivative · entry 2 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 232,871 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.